MAP2K7 and melanoma: Although we do not know the concentration we achieve in mice at 25 mg/kg/day, the levels reached in patients are in the range of the concentration we used (5–10 μM) to sensitize melanoma cells to BRAF or MEK inhibitor-induced cell death in vitro.